Page last updated: 2024-08-25

methotrexate and Leprosy, Cutaneous

methotrexate has been researched along with Leprosy, Cutaneous in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's4 (80.00)2.80

Authors

AuthorsStudies
Bagot, M; Bertolotti, A; Bouaziz, JD; Cambau, E; Chauveau, M; Duhamel, E; Hau, E; Jachiet, M; Jaume, L; Le, B; Mahé, A; Maisonobe, T; Monsel, G; Mougari, F; Petit, A1
Alinda, MD; Butlin, CR; Darlong, J; de Barros, B; Dias, VLA; Doni, S; Hagge, DA; Lambert, SM; Listiawan, MY; Lockwood, D; Nery, JAC; Neupane, KD; Nicholls, PG; Pai, VV; Rozario, BJ; Sales, AM; Shah, M; Shrestha, D; Walker, SL; Yitaye, AM1
Agarwal, A; B, S; Khurana, A; Muddebihal, A; Paliwal, P; Raina, A; Sardana, K; Saxena, S1
Agrawal, D; Ahuja, A; Rani, S; Sardana, K; Singh, S1
Babu, R; Kar, BR1

Trials

1 trial(s) available for methotrexate and Leprosy, Cutaneous

ArticleYear
Methotrexate and prednisolone study in erythema nodosum leprosum (MaPs in ENL) protocol: a double-blind randomised clinical trial.
    BMJ open, 2020, 11-17, Volume: 10, Issue:11

    Topics: Bangladesh; Brazil; Erythema Nodosum; Ethiopia; Humans; India; Indonesia; Leprostatic Agents; Leprosy, Lepromatous; London; Methotrexate; Nepal; Prednisolone

2020

Other Studies

4 other study(ies) available for methotrexate and Leprosy, Cutaneous

ArticleYear
Methotrexate as a corticosteroid-sparing agent in leprosy reactions: A French multicenter retrospective study.
    PLoS neglected tropical diseases, 2023, Volume: 17, Issue:4

    Topics: Erythema Nodosum; Female; Glucocorticoids; Humans; Leprosy; Leprosy, Lepromatous; Male; Methotrexate; Recurrence; Retrospective Studies

2023
Severe type 2 leprosy reaction with COVID-19 with a favourable outcome despite continued use of corticosteroids and methotrexate and a hypothesis on the possible immunological consequences.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2021, Volume: 103

    Topics: Adrenal Cortex Hormones; Adult; COVID-19; COVID-19 Drug Treatment; Erythema Nodosum; Humans; Immunosuppressive Agents; Leprosy, Lepromatous; Male; Methotrexate; SARS-CoV-2

2021
An uncommon variant of erythema nodosum leprosum responding well to methotrexate: Report of two cases.
    Tropical doctor, 2021, Volume: 51, Issue:4

    Topics: Erythema Nodosum; Humans; Leprosy; Leprosy, Lepromatous; Methotrexate

2021
Methotrexate in resistant ENL.
    International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association, 2004, Volume: 72, Issue:4

    Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Drug Synergism; Erythema Nodosum; Humans; Immunosuppressive Agents; Leprosy, Lepromatous; Male; Methotrexate; Middle Aged; Prednisolone; Treatment Failure; Treatment Outcome

2004